ArticleLeukemia2019
The first-in-human study of the pan-PIM kinase inhibitor PIM447 in patients with relapsed and/or refractory multiple myeloma.
Marc S Raab et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it